Literature DB >> 29457853

Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells.

Yoko Fujii-Nishimura1, Ken Yamazaki1, Yohei Masugi1, Junya Douguchi1, Yutaka Kurebayashi1, Naoto Kubota1, Hidenori Ojima1, Minoru Kitago2, Masahiro Shinoda2, Akinori Hashiguchi1, Michiie Sakamoto1.   

Abstract

Epithelial-mesenchymal transition (EMT) promotes invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC). However, the importance of its reverse process, mesenchymal-epithelial transition (MET), for PDAC remains unclear. We aimed to characterize the histological finding "focal differentiation" in PDAC at perineural invasion sites in the context of MET and to investigate the role of Schwann cells in inducing tumor MET. Tumor differentiation and immunohistochemical expressions of E-cadherin, SMAD3, and vimentin at perineural invasion sites were examined in 168 PDAC tissues. Four PDAC cell lines were co-cultured with Schwann cells to investigate cell morphology, motility, or EMT-related markers using immunocytochemistry and quantitative PCR. Of 168 tumors, 124 (74%) showed focal differentiation with enhanced E-cadherin membrane expression (P < 0.001) and decreased nuclear accumulation of SMAD3 (P < 0.001). Among 115 PDACs harboring grade 1/2 tumor, tumors with focal differentiation showed worse survival compared to those without focal differentiation (P = 0.019). PDAC cells co-cultured with Schwann cells demonstrated a sheet-like appearance, increased E-cadherin expression, decreased expressions of SMAD3 and vimentin, and reduced cell motility. In conclusion, MET-like change is induced by Schwann cells, suggesting that Schwann cells contribute to PDAC colonization in pancreatic nerves through activating the MET machinery inside tumor cells in the pancreatic tumor microenvironment.
© 2018 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Schwann cells; focal differentiation; mesenchymal-epithelial transition; pancreatic ductal adenocarcinoma; perineural invasion

Mesh:

Year:  2018        PMID: 29457853     DOI: 10.1111/pin.12641

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

1.  Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Ekaterina Petrova; Verena Zielinski; Louisa Bolm; Cleopatra Schreiber; Juliana Knief; Christoph Thorns; Peter Bronsert; Sylvia Timme-Bronsert; Dirk Bausch; Sven Perner; Tobias Keck; Ulrich Wellner
Journal:  Virchows Arch       Date:  2019-11-30       Impact factor: 4.064

2.  TNFα promotes oral cancer growth, pain, and Schwann cell activation.

Authors:  Elizabeth Salvo; Nguyen H Tu; Nicole N Scheff; Zinaida A Dubeykovskaya; Shruti A Chavan; Bradley E Aouizerat; Yi Ye
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

Review 3.  Molecular and Cellular Mechanisms of Perineural Invasion in Oral Squamous Cell Carcinoma: Potential Targets for Therapeutic Intervention.

Authors:  Carly I Misztal; Carlos Green; Christine Mei; Rita Bhatia; Jaylou M Velez Torres; Brandon Kamrava; Seo Moon; Elizabeth Nicolli; Donald Weed; Zoukaa Sargi; Christine T Dinh
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 4.  Schwann Cells in Digestive System Disorders.

Authors:  Karina Goluba; Liga Kunrade; Una Riekstina; Vadims Parfejevs
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

5.  A HPV16-related prognostic indicator for head and neck squamous cell carcinoma.

Authors:  Qian Zhang; Yongfeng Chen; Shi-Qi Hu; Yu-Mei Pu; Kai Zhang; Yu-Xin Wang
Journal:  Ann Transl Med       Date:  2020-11

6.  Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer.

Authors:  Wunai Zhang; Rui He; Wenbin Yang; Yan Zhang; Qinggong Yuan; Jixin Wang; Yang Liu; Shuo Chen; Simei Zhang; Weifan Zhang; Zeen Zhu; Jing Zhang; Zheng Wang; Junhui Li
Journal:  J Exp Clin Cancer Res       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.